Market Research Logo

United States Contrast Agents Market Outlook to 2022

United States Contrast Agents Market Outlook to 2022

Summary

GlobalData’s new report, United States Contrast Agents Market Outlook to 2022, provides key market data on the United States Contrast Agents market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - Computed Tomography (CT) Contrast Agents, Magnetic Resonance Imaging (MRI) Contrast Agents and Ultrasound Contrast Agents (Microbubbles).

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Contrast Agents market segements - Computed Tomography (CT) Contrast Agents, Magnetic Resonance Imaging (MRI) Contrast Agents and Ultrasound Contrast Agents (Microbubbles).
  • Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
  • 2015 company shares and distribution shares data for each of the market segements.
  • Global corporate-level profiles of key companies operating within the United States Contrast Agents market.
  • Key players covered include Bayer HealthCare AG, GE Healthcare Limited, Bracco Imaging S.p.A. and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Contrast Agents Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Contrast Agents Market, United States
3.1 Contrast Agents Market, United States, Revenue ($m), 2008-2015
3.2 Contrast Agents Market, United States, Revenue ($m), 2015-2022
3.2.1 Computed Tomography (CT) Contrast Agents Market, United States, Revenue ($m), by Segment, 2008-2015
3.2.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Revenue ($m), by Segment, 2008-2015
3.2.3 Computed Tomography (CT) Contrast Agents Market, United States, Revenue ($m), by Segment, 2015-2022
3.2.4 Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Revenue ($m), by Segment, 2015-2022
3.3 Contrast Agents Market, United States, Volume (Units), 2008-2015
3.4 Contrast Agents Market, United States, Volume (Units), 2015-2022
3.4.1 Computed Tomography (CT) Contrast Agents Market, United States, Volume (Units), by Segment, 2008-2015
3.4.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Volume (Units), by Segment, 2008-2015
3.4.3 Computed Tomography (CT) Contrast Agents Market, United States, Volume (Units), by Segment, 2015-2022
3.4.4 Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Volume (Units), by Segment, 2015-2022
3.5 Contrast Agents Market, United States, Average Price ($), 2008-2022
3.6 Contrast Agents Market, United States, Distribution Share by Revenue ($m), 2014-2015
3.7 Contrast Agents Market, United States, Company Share by Revenue ($m), 2015
4 Overview of Key Companies in United States, Contrast Agents Market
4.1 GE Healthcare Ltd
4.1.1 Company Overview
4.2 Bracco Imaging SpA
4.2.1 Company Overview
4.3 Bayer HealthCare AG
4.3.1 Company Overview
4.4 Guerbet SA
4.4.1 Company Overview
5 Recent Developments
5.1 Product News
5.1.1 Dec 22, 2016: Progenics Pharmaceuticals Announces Independent Committee’s Positive Recommendation for Continuation of Phase 3 Clinical Trial of SPECT/CT Imaging Agent 1404
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Distribution Share Analysis
6.1.7 Benchmarking
6.2 GlobalData Consulting
6.3 Contact Us
6.4 Disclaimer
1.1 List of Tables
Table 1: Contrast Agents Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Table 2: Contrast Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 3: Computed Tomography (CT) Contrast Agents Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Table 4: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Table 5: Computed Tomography (CT) Contrast Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 6: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 7: Contrast Agents Market, United States, Volume (Units), Historic, 2008-2015
Table 8: Contrast Agents Market, United States, Volume (Units), Forecast, 2015-2022
Table 9: Computed Tomography (CT) Contrast Agents Market, United States, Volume (Units), Historic, 2008-2015
Table 10: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Volume (Units), Historic, 2008-2015
Table 11: Computed Tomography (CT) Contrast Agents Market, United States, Volume (Units), Forecast, 2015-2022
Table 12: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Volume (Units), Forecast, 2015-2022
Table 13: Contrast Agents Market, United States, Average Price ($) Historic, 2008-2022
Table 14: Contrast Agents Market, United States, Average Price ($), Forecast, 2015-2022
Table 15: Contrast Agents Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 16: Contrast Agents Market, United States, Company Share by Revenue ($m), USD Constant, 2015
Table 17: Total Number of Primary Research Participants, Diagnostic Imaging Equipment Market, by Country
1.2 List of Figures
Figure 1: Contrast Agents Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 2: Contrast Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 3: Computed Tomography (CT) Contrast Agents Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 4: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 5: Computed Tomography (CT) Contrast Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 6: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 7: Contrast Agents Market, United States, Volume (Units), Historic, 2008-2015
Figure 8: Contrast Agents Market, United States, Volume (Units), Forecast, 2015-2022
Figure 9: Computed Tomography (CT) Contrast Agents Market, United States, Volume (Units), Historic, 2008-2015
Figure 10: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Volume (Units), Historic, 2008-2015
Figure 11: Computed Tomography (CT) Contrast Agents Market, United States, Volume (Units), Forecast, 2015-2022
Figure 12: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United States, Volume (Units), Forecast, 2015-2022
Figure 13: Contrast Agents Market, United States, Company Share (%) 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report